Characteristics | Total | Treatment Success n (%) | Unadjusted OR (95 % CI) | P-value* | Adjustedb OR (95 % CI) | P-value* |
---|---|---|---|---|---|---|
Overall | 730 | 410 (56.2) | ||||
Type of retreatment case | ||||||
Classical retreatment cases | 398 | 243 (61.1) | 1.00 | 1.00 | ||
Retreatment ‘others’ | 332 | 167 (50.3) | 0.65 (0.48, 0.87) | 0.004** | 0.60 (0.44, 0.82) | 0.001** |
HIV status | ||||||
Positive | 424 | 236 (55.7) | 1.00 | 1.00 | ||
Negative | 266 | 159 (59.8) | 1.18 (0.87, 1.62) | 0.288 | 1.13 (0.82, 1.56) | 0.452 |
Unknown | 40 | 15 (37.5) | 0.48 (0.24, 0.93) | 0.030** | 0.44 (0.22, 0.88) | 0.020** |
Age groupa | ||||||
15-44 | 509 | 292 (57.4) | 1.00 | 1.00 | ||
<15 | 39 | 27 (69.2) | 1.67 (0.83, 3.37) | 0.143 | 2.32 (1.12, 4.81) | 0.024** |
≥45 | 181 | 90 (49.7) | 0.73 (0.52, 1.03) | 0.073 | 0.75 (0.53, 1.06) | 0.102 |
Sex | ||||||
Male | 523 | 296 (56.6) | 1.00 | 1.00 | ||
Female | 207 | 114 (55.1) | 0.94 (0.68, 1.30) | 0.708 | 0.97 (0.69, 1.35) | 0.844 |
Anatomical site | ||||||
Pulmonary | 689 | 388 (56.3) | 1.00 | |||
Extrapulmonary | 41 | 22 (53.7) | 0.90 (0.48, 1.69) | 0.739 | ||
Treatment regimen | ||||||
Retreatment: 2SRHZE/1RHZE/5RHE | 582 | 322 (55.3) | 1.00 | |||
New: 2RHZE/6EH or 2RHZ/4RH | 116 | 66 (56.9) | 1.07 (0.71, 1.59) | 0.756 | ||
Other regimen | 32 | 22 (68.8) | 1.78 (0.83, 3.82) | 0.137 |